Joint Stock Co Pharmstandard Public, 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 57,772 shares at $4.55 ($263K) on 2016-08-24, disclosed to the SEC on 2016-08-25.
Open-market purchase of $263k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ARGS | BUY | 2016-10-04 | $391K | — | Filing → |
| ARGS | BUY | 2016-09-21 | $420K | — | Filing → |
| ARGS | BUY | 2016-09-20 | $501K | — | Filing → |